Previous 10 | Next 10 |
SOUTH SAN FRANCISCO, Calif., March 06, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME), a leading human genetics and biopharmaceutical company, released three new genetic reports for 23andMe+ members on breast, colorectal and prostate cancer. The reports are based on statistical models ...
SOUTH SAN FRANCISCO, Calif., March 05, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (“23andMe”), a leading human genetics and biopharmaceutical company, today announced an oral presentation and two poster presentations on two of the Company’s immuno-oncology prog...
2024-02-17 01:01:00 ET Summary While we may use statistical measures like volatility or correlation to measure risk in practice, risk is not a statistical abstraction. Business owners can try to insulate themselves from catastrophic risk, but those protections may not exist, and e...
2024-02-13 09:53:00 ET Genetic-testing company 23andMe (NASDAQ: ME) is a household name, but does that make it a smart investment? After all, if the tangible health benefits of learning more about your genome are as significant as the company claims, people would be rushing en masse...
2024-02-08 13:15:15 ET More on 23andMe 23andMe Holding Co. (ME) Q3 2024 Earnings Call Transcript 23andMe GAAP EPS of -$0.58, revenue of $44.7M misses by $11.6M 23andMe reportedly mulling split of company to maintain listing Seeking Alpha’s Quant Rating...
2024-02-07 21:22:04 ET 23andMe Holding Co. (ME) Q3 2024 Earnings Conference Call February 07, 2024 04:30 PM ET Company Participants Ian Cooney - Senior Director of Investor Relations Anne Wojcicki - Co-Founder and Chief Executive Officer Joseph Selsavage - Interi...
2024-02-07 16:48:07 ET More on 23andMe 23andMe reportedly mulling split of company to maintain listing 23andMe facing mounting litigation over hacking incident Seeking Alpha’s Quant Rating on 23andMe Historical earnings data for 23andMe Financi...
2024-02-07 16:03:18 ET More on 23andMe 23andMe facing mounting litigation over hacking incident Hackers accessed personal data for 6.9M 23andMe users: report Seeking Alpha’s Quant Rating on 23andMe Historical earnings data for 23andMe Financial...
SOUTH SAN FRANCISCO, Calif., Feb. 07, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME), a leading human genetics and biopharmaceutical company, reported its financial results for the third quarter of fiscal year 2024 (FY24), which ended December 31, 2023. Key Results Report...
Penske Automotive Group Inc. (PAG) is expected to report $3.66 for Q4 2023 Copa Holdings S.A. Class A (CPA) is expected to report $3.9 for Q4 2023 Wynn Resorts Limited (WYNN) is expected to report $1.12 for Q4 2023 U-Haul Holding Co Com (UHAL) is expected to report $0.82 for Q3 2024 ...
News, Short Squeeze, Breakout and More Instantly...
SOUTH SAN FRANCISCO, Calif., June 28, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME), a leading preventive health and therapeutics company, and Nightingale Health Plc, a pioneer in biomarker testing and risk prediction, today announced a strategic collaboration to pilot Nightingale Hea...
SOUTH SAN FRANCISCO, Calif., June 05, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME), a leading human genetics and biopharmaceutical company, today released a new genetic Bipolar Disorder report (Powered by 23andMe Research) for 23andMe+ Premium members, informing them if they are at h...
2024-06-04 12:48:12 ET Genetic database builder 23andMe (NASDAQ: ME) stock slid 10% through 12:05 p.m. ET Tuesday. Curiously, though, the news that 23andMe reported today seemed generally of the "good" variety. The company announced a collaboration with the nonprofit Colorectal ...